SCHEMBL19078992

SCHEMBL19078992

COC(=O)c1cccc(CCCCCBr)c1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP4A11 Q02928 5/20 0.76
▸ CYP4F2 P78329 4/20 0.76
▸ LOXL2 Q9Y4K0 1/20 0.60
▸ SLC7A5 Q01650 1/20 0.52
▸ DHODH Q02127 1/20 0.50
▸ FOLH1 Q04609 1/20 0.49
▸ MRGPRX4 Q96LA9 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HPGD P15428 1/20 0.49
▸ FAAH O00519 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HIF1A Q16665 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ MDH1 P40925 1/20 0.46
▸ PARP1 P09874 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19078986 0.98 CYP4A11 (0.78) CYP4A11CYP4F2LOXL2SLC7A5DHODH
SCHEMBL6614812 0.95 CYP4A11 (0.73) CYP4A11CYP4F2LOXL2SLC7A5DHODH
SCHEMBL244703 0.89 CYP4F2 (0.73) CYP4A11CYP4F2LOXL2SLC7A5FOLH1
SCHEMBL26239703 0.88 CYP4F2 (0.76) CYP4A11CYP4F2LOXL2SLC7A5MDH1
SCHEMBL15174613 0.88 CYP4F2 (0.76) CYP4A11CYP4F2LOXL2SLC7A5MDH1
SCHEMBL15174508 0.88 CYP4F2 (0.76) CYP4A11CYP4F2LOXL2SLC7A5MDH1
SCHEMBL31752933 0.88 CYP4A11 (0.97) CYP4A11CYP4F2LOXL2SLC7A5DHODH
SCHEMBL19889923 0.87 CYP4F2 (0.74) CYP4A11CYP4F2LOXL2SLC7A5DHODH
SCHEMBL18540811 0.86 CYP4A11 (1.00) CYP4A11CYP4F2LOXL2SLC7A5DHODH
SCHEMBL70173 0.85 CYP4F2 (0.83) CYP4A11CYP4F2LOXL2SLC7A5DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3397614-B1 IONIZABLE CATIONIC LIPID ARCTURUS THERAPEUTICS INC (US) 2022-05-18 — — EP disclosed
WO-2017117530-A9 IONIZABLE CATIONIC LIPID ARCTURUS THERAPEUTICS, INC. (US) 2021-03-11 — — WO disclosed
US-20180050987-A1 AROMATIC IONIZABLE CATIONIC LIPID ARCTURUS THERAPEUTICS, INC. 2018-02-22 — — US disclosed
US-9834510-B2 Aromatic ionizable cationic lipid ARCTURUS THERAPEUTICS, INC. (US) 2017-12-05 — — US disclosed
US-9834510-B2 Aromatic ionizable cationic lipid ARCTURUS THERAPEUTICS, INC. (US) 2017-12-05 — — US disclosed
WO-2017117530-A1 IONIZABLE CATIONIC LIPID ARCTURUS THERAPEUTICS, INC. (US) 2017-07-06 — — WO disclosed
US-20170190661-A1 Aromatic Ionizable Cationic Lipid ARCTURUS THERAPEUTICS, INC. 2017-07-06 — — US disclosed
US-20170190661-A1 Aromatic Ionizable Cationic Lipid ARCTURUS THERAPEUTICS, INC. 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180050987-A1 AROMATIC IONIZABLE CATIONIC LIPID SGMS1, SLCO4C1, SLCO2B1 CYP4A11 433/4885CYP4F2 643/4885LOXL2 427/4885
US-20170190661-A1 Aromatic Ionizable Cationic Lipid SGMS1, SLC7A1, SLCO2B1 CYP4A11 476/4885CYP4F2 494/4885LOXL2 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback